Download PDF
Thromb Haemost 2003; 90(05): 770-771
DOI: 10.1055/s-0037-1613495
Editorial Focus
Schattauer GmbH

Extending knowledge on inherited platelet disorders associated with thrombocytopenia

Catherine P. M. Hayward
1   Departments of Pathology and Molecular Medicine, and Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received 25 August 2003

Accepted after revision 07 September 2003

Publication Date:
06 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Hayward CPM. Inherited platelet disorders. Current Opin Hematol 2003; 10: 362-8.
    PubMedGoogle Scholar
  • 2 Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003; 1: 1628-36.
    CrossrefPubMedGoogle Scholar
  • 3 Hayward CPM. Inherited disorders of platelet α-granules. Platelets 1997; 8: 197-210.
    CrossrefPubMedGoogle Scholar
  • 4 Van Geet C, Freson K, Devos R. et al Hereditary thrombocytopenias. In Platelets in thrombotic and non-thrombotic disorders. Patho-physiology, pharmacology and therapeutics. Edited by Gresele P, Page C, Fuster V, Vermylen J. Cambridge UK: The Press Syndicate of the University of Cambridge; 2002: 515-27.
    Google Scholar
  • 5 Favier R, Jondeau K, Boutard P. et al Paris-Trousseau Syndrome: clinical, hematological, and molecular data of ten new cases. Thromb Haemost 2003; 90: 893-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Breton-Gorius J, Favier R, Guichard J. et al A new congenital dysmegakaryopoiesis thrombocytopenia (Paris-Trousseau) associated with giant platelets and chromosome 11 deletion at 11q23. Blood 1995; 85: 1805-14.
    PubMedGoogle Scholar
  • 7 Hartwig J, Italiano Jr J. The birth of the platelet. J Thromb Haemost 2003; 1: 1580-6.
    CrossrefPubMedGoogle Scholar
  • 8 Kaushansky K. Thrombopoietin: a tool for understanding thrombopoiesis. J Thromb Hae-most 2003; 1: 1587-92.
    CrossrefPubMedGoogle Scholar
  • 9 Heijnen HF, Debili N, Vainchencker W. et al Multivesicular bodies are an intermediate stage in the formation of platelet α-granules. Blood 1998; 91: 2313-25.
    PubMedGoogle Scholar
  • 10 Youssefian T, Cramer EM. Megakaryocyte dense granule components are sorted in multi-vesicular bodies. Blood 2000; 95: 4004-7.
    PubMedGoogle Scholar
  • 11 Drouin A, Favier R, Masse J-M. et al Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001; 98: 1382-91.
    CrossrefPubMedGoogle Scholar
  • 12 Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001; 19: 397-407.
    CrossrefPubMedGoogle Scholar
  • 13 Hart A, Melet F, Grossfeld P. et al Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-77.
    CrossrefPubMedGoogle Scholar
  • 14 Eisbacher M, Holmes ML, Newton A. et al Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol 2003; 23: 3427-41.
    CrossrefPubMedGoogle Scholar
  • 15 Kawada H, Ito T, Pharr PN. et al Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int J Hematol 2001; 73: 463-468.
    CrossrefPubMedGoogle Scholar
  • 16 Starck J, Cohet N, Gonnet C. et al Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol 2003; 23: 1390-1402.
    CrossrefPubMedGoogle Scholar